RxDoctor Payments DataLook up a doctor →

Steven Toenjes, MD

Neurology · Jacksonville, FLNPI 1679585764

Payments from drug & device makers

$6,894,503in general payments, 2019–2025

Across 1,955 payments — averaging $3526.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$5.9M
  • Amgen$256K
  • AbbVie$209K
  • Lilly USA, LLC$151K
  • Pfizer$67K
  • Lundbeck LLC$52K
  • plus $211K from 54 others
$16,471in research payments, 2019–2025

Across 7 payments — averaging $2352.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$16K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly56$5,947,832
Amgen(2 entities)261$256,488
AbbVie(2 entities)469$208,717
Lilly USA, LLC285$150,579
Pfizer41$67,448
Lundbeck LLC105$52,226
Merz Pharmaceuticals, LLC10$46,051
E.r. Squibb & Sons, L.L.C.6$44,493
Teva Pharmaceuticals USA, Inc.100$35,167
Eisai Inc.74$32,115
Takeda Pharmaceuticals U.S.A., Inc.51$21,714
Axsome Therapeutics, Inc.27$20,593
Jazz Pharmaceuticals Inc.47$1,402
Novartis73$1,229
Neurocrine Biosciences, Inc.22$628
Argenx US, Inc.15$593
Biogen21$568
Amneal Pharmaceuticals LLC20$552
AstraZeneca(2 entities)23$456
MDD US Operations, LLC13$434
Acadia Pharmaceuticals Inc12$335
Impel Pharmaceuticals Inc.15$296
Bristol Myers Squibb12$287
EMD Serono, Inc.10$265
UCB, Inc.6$222
Octapharma USA, Inc.9$212
Upsher-smith Laboratories LLC10$201
Biohaven Pharmaceutical Holding Company Ltd.11$194
Supernus Pharmaceuticals, Inc.26$192
SK Life Science, Inc.3$191
Otsuka America Pharmaceutical, Inc.8$188
Harmony Biosciences LLC5$155
Neurelis, Inc.7$153
Alnylam Pharmaceuticals Inc.8$149
Biohaven Pharmaceuticals, Inc.7$149
Insightec,inc2$135
Kyowa Kirin, Inc.8$135
Sanofi6$133
TG Therapeutics, Inc.1$126
Boston Scientific5$112
Sunovion Pharmaceuticals Inc.5$107
ANI Pharmaceuticals, Inc.4$107
CSL Behring4$106
Adamas Pharmaceuticals, Inc.5$91
Avion Pharmaceuticals3$85
GE HealthCare3$72
Bausch Health US, LLC3$71
Johnson & Johnson3$46
Genentech USA, Inc.3$45
Avanir Pharmaceuticals, Inc.2$42
Genentech, Inc.1$40
Tersera Therapeutics LLC2$39
Scilex Pharmaceuticals Inc.2$38
Zyla Life Sciences, Inc.2$35
Corium, LLC1$34
Microtransponder, Inc.1$34
Vertical Pharmaceuticals, LLC2$32
Arbor Pharmaceuticals, Inc.2$31
Impel Pharmaceuticals LLC2$31
Averitas Pharma Inc.1$30

How this compares

$6,894,503 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$406,298
Medicare patients
560
Services billed
45,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →